Non Perianal Fistulas in Crohn's Disease and Short Bowel Syndrome: What We Can Do?

Zildzic, Muharem; Alibegovic, Ervin
December 2009
Medicinski Arhiv;2009, Vol. 63 Issue 6, p354
Academic Journal
Case Study
Crohn s disease (CD) is a lifelong disease arising from an interaction between genetic and environmental factors, but seen predominantly in the developed countries of the world. The precise etiology is unknown and therefore a causal treatment is not yet available. Fistulating Crohn's disease includes fistulas arising in the perianal area, together with those communicating between the intestine and other organs or the abdominal wall. Non perianal fistulas include fistulas communicating with other viscera (urinary bladder, vagina), loops of intestine (enteroenteral fistulas) or the abdominal wall (enterocutaneus fistulas). The diagnostic approach is a crucial aspect in the management of fistulating CD as the findings influence the therapeutic strategy. Short bowel syndrome caused by extensive bowel resection should be initially treated with nutritional support and can caused serious treatment and reevaluating problems. We review this uncommon manifestation in a high risk patient after multiple operations and severely shortened bowel and also with non perianal fistulating CD.


Related Articles

  • Benign rectovaginal fistulas: management and results of a personal series. Devesa, J. M.; Devesa, M.; Velasco, G. R.; Vicente, R.; García-Moreno, F.; Rey, A.; López-Hervás, P.; Die, J.; Molina, J. M. // Techniques in Coloproctology;Jun2007, Vol. 11 Issue 2, p128 

    Treatment of benign rectovaginal fistula has a high failure rate and entails difficult decisions. The purpose of this retrospective study was to clarify the concepts which may improve its management. Between 1983 and 2004, 46 consecutive women of median age 41 years were treated by the same...

  • Management of perianal Crohn's disease. Hobbiss, J. H.; Schofield, Philip F. // Journal of the Royal Society of Medicine;Jun1982, Vol. 75 Issue 6, p414 

    Symptomatic anal disease (excluding skin tags) was observed in 49 out of 151 successive patients treated for Crohn's disease. Two main types of anal disease were encountered: anal ulceration (23 patients) and anal abscesses and fistulae (26 patients). The ulcer group rarely required local...

  • The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype. Matthias Jürgens; Brand, Stephan; Laubender, Rüdiger P.; Seiderer, Julia; Glas, Jürgen; Wetzke, Martin; Wagner, Johanna; Pfennig, Simone; Tillack, Cornelia; Beigel, Florian; Weidinger, Maria; Schnitzler, Fabian; Kreis, Martin E.; Göke, Burkhard; Lohse, Peter; Herrmann, Karin; Ochsenkühn, Thomas // Journal of Gastroenterology;Jul2010, Vol. 45 Issue 7, p721 

    We analyzed the prevalence of concomitant intestinal stenosis in patients with fistulizing Crohn’s disease (CD), including the NOD2/CARD15 and IL23R genotype status. Medical records of n = 1,110 patients with inflammatory bowel diseases were screened for patients with fistulizing and...

  • Pouch function and quality of life after successful management of pouch-related septic complications in patients with ulcerative colitis. Mennigen, Rudolf; Senninger, Norbert; Bruewer, Matthias; Rijcken, Emile // Langenbeck's Archives of Surgery;Jan2012, Vol. 397 Issue 1, p37 

    Purpose: Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis is associated with pouch-related septic complications (PRSC) in 10% of patients. This study questioned if PRSC have a negative impact on pouch function and quality of life. Patients and methods:...

  • Laser ablation of complex perianal fistulas preserves continence and is a rectum-sparing... Bodzin, Jason H. // American Surgeon;Jul1998, Vol. 64 Issue 7, p627 

    Presents a review of the inflammatory bowel disease surgical database of the author for Crohn's disease (CD) patients who had a surgical approach to perianal fistula disease. Effectiveness of laser ablation of complex perianal fistulas; Assessment of the quality of life of the patients;...

  • Information management and informatics: need for a modern pathology service. Jones, Rick; O'Connor, John // Annals of Clinical Biochemistry;May2004, Vol. 41 Issue 3, p183 

    Requirements for information technology in pathology now extend well beyond the provision of purely analytical data. With the aim of achieving seamless integration of laboratory data into the total clinical pathway, 'informatics' - the art and science of turning data into useful information - is...

  • New therapeutic approach in inflammatory bowel disease. PAPA, A.; MOCCI, G.; SCALDAFERRI, F.; BONIZZI, M.; FELICE, C.; ANDRISANI, G.; GASBARRINI, A. // European Review for Medical & Pharmacological Sciences;Jan2009 Supplement, Vol. 13 Issue S-1, p33 

    In the last decade, biologic agents, in particular infliximab and adalimumab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually...

  • Utilization of Health Care Resources by Individuals with Inflammatory Bowel Disease in the United States: A Profile of Time Since Diagnosis. Longobardi, Teresa; Jacobs, Phillip; Bernstein, Charles N. // American Journal of Gastroenterology;Apr2004, Vol. 99 Issue 4, p650 

    BACKGROUND: There are no cost studies of inflammatory bowel disease (IBD) that describe its impact on resource utilization or treatment costs over long periods of time. Our aim was to determine if there are observable trends in health-care resource utilization by adults with IBD depending on...

  • The Manitoba IBD Index: Evidence for a New and Simple Indicator of IBD Activity. Clara, Ian; Lix, Lisa M.; Walker, John R.; Graff, Lesley A.; Miller, Norine; Rogala, Linda; Rawsthorne, Patricia; Bernstein, Charles N. // American Journal of Gastroenterology;Jul2009, Vol. 104 Issue 7, p1754 

    OBJECTIVES:A single-item indicator of disease activity over an extended period of time, the Manitoba Inflammatory Bowel Disease Index (MIBDI), is introduced and compared against several standard measures for assessing activity in patients with Crohn's disease (CD) and ulcerative colitis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics